Physician profile
Diego Celli
NPI 1285194886
$19,444.73
in general payments reported to CMS, 2019-2025
26 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,084 · 2023: $1,660 · 2024: $6,440 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $7,317 · Education: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,737.11 |
| Travel and Lodging | $7,317.25 |
| Education | $306.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $10,962.77 | 2022-2025 | Optis, Perclose Proglide, Supera |
| Boston Scientific Corporation | $3,241.74 | 2023-2025 | Avvigo Guidance System, Sentinel, Jetstream Sc |
| Edwards Lifesciences Corporation | $2,018.02 | 2024-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $557.40 | 2024-2025 | Venaseal, Corevalve Evolut R, Onyx Frontier |
| Cardiva Medical, INC. | $410.09 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Abiomed | $248.48 | 2025 | |
| Pfizer INC. | $235.68 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $219.96 | 2024-2025 | Opsumit, Uptravi |
| Shockwave Medical, INC | $190.45 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $182.68 | 2025 | Turnpike, Trapliner |
| Penumbra, INC. | $175.00 | 2024 | Indigo System |
| Cardiovascular Systems INC. | $155.73 | 2022-2023 | Diamondback Coronary |
| Bridgebio Pharma, INC. | $121.13 | 2025 | Attruby |
| Amgen INC. | $119.50 | 2022-2025 | Repatha, Repatha |
| Cvrx, INC. | $86.53 | 2024 | Barostim Neo System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $86.02 | 2022-2025 | Wainua |
| Inari Medical, INC. | $85.39 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $73.54 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $69.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $54.40 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $44.55 | 2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $32.57 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $27.35 | 2023 | Inpefa |
| Heartflow, INC. | $17.12 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.24 | 2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diego Celli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.